Literature DB >> 16500900

Role of the CCAAT/enhancer-binding protein NFATc2 transcription factor cascade in the induction of secretory phospholipase A2.

Teddy T C Yang1, Peter M U Ung, Mercedes Rincón, Chi-Wing Chow.   

Abstract

Inflammatory cytokines such as interleukin-1 and tumor necrosis factor-alpha modulate a transcription factor cascade in the liver to induce and sustain an acute and systemic defense against foreign entities. The transcription factors involved include NF-kappaB, STAT, and CCAAT/enhancer-binding protein (C/EBP). Whether the NFAT group of transcription factors (which was first characterized as playing an important role in cytokine gene expression in the adaptive response in immune cells) participates in the acute-phase response in hepatocytes is not known. Here, we have investigated whether NFAT is part of the transcription factor cascade in hepatocytes during inflammatory stress. We report that interleukin-1 or tumor necrosis factor-alpha increases expression of and activates NFATc2. C/EBP-mediated NFATc2 induction is temporally required for expression of type IIA secretory phospholipase A2. NFATc2 is also required for expression of phospholipase D1 and the calcium-binding protein S100A3. Thus, a C/EBP-NFATc2 transcription factor cascade provides an additional means to modulate the acute-phase response upon stimulation with inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500900     DOI: 10.1074/jbc.M511214200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.

Authors:  Mario Menschikowski; Albert Hagelgans; Eugene Gussakovsky; Heike Kostka; Elena L Paley; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

2.  The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.

Authors:  Misook Oh; Asim Dey; Robert D Gerard; Joseph A Hill; Beverly A Rothermel
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

3.  Role of transcription factor NFAT in glucose and insulin homeostasis.

Authors:  Teddy T C Yang; Hee Yun Suk; Xiaoyong Yang; Opeyemi Olabisi; Raymond Y L Yu; Jorge Durand; Linda A Jelicks; Ja-Young Kim; Philipp E Scherer; Yuhua Wang; Yun Feng; Luciano Rossetti; Isabella A Graef; Gerald R Crabtree; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

Review 4.  Functional regulation of phospholipase D expression in cancer and inflammation.

Authors:  Dong Woo Kang; Kang-Yell Choi; Do Sik Min
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

5.  Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice.

Authors:  Rajkumar Noubade; Graeme Milligan; James F Zachary; Elizabeth P Blankenhorn; Roxana del Rio; Mercedes Rincon; Cory Teuscher
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 6.  The effects of IL-6 on CD4 T cell responses.

Authors:  Oliver Dienz; Mercedes Rincon
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

7.  Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity.

Authors:  Michelle A Sama; Diana M Mathis; Jennifer L Furman; Hafiz Mohmmad Abdul; Irina A Artiushin; Susan D Kraner; Christopher M Norris
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

8.  CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.

Authors:  Satinder Dahiya; Yujie Liu; Michael R Nonnemacher; Will Dampier; Brian Wigdahl
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.